Liquidia Corporation LQDA
$68.88
▼ -0.56% 24H
About
Liquidia Corporation is a biopharmaceutical company focused on therapies for rare cardiopulmonary diseases, primarily in the United States. The company develops, manufactures, and commercializes treatments aimed at addressing unmet patient needs in pulmonary hypertension. Its key product, Yutrepia, is an inhaled dry po…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees170
TickerLQDA
Statistics
Market Cap$6.08B
Revenue (TTM)$158.3M
Net Income-$68.9M
Net Margin-43.5%
EPS$-0.80
P/E386.24
P/S20.27
P/B53.38
EV/EBITDA121.27
ROE28.2%
Dividend Yield—
Price$68.88
Data: Twelve Data · Revenue = mcap / P/S